查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1721213

周邊動脈疾病治療市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Peripheral Arterial Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 245 Pages | 商品交期: 2-10個工作天內

價格

周邊動脈疾病治療市場-報告範圍

TMR 關於全球周邊動脈疾病治療市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2019 年至 2035 年期間全球周邊動脈疾病治療市場的收入，以 2025 年為基準年，2035 年為預測年。報告中也提供了2025年至2035年全球周邊動脈疾病治療市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初步研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了訪談。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解周邊動脈疾病治療市場。

市場概況
2024 年的市場價值 29億美元
2035年的市場價值 64億美元
複合年成長率 7.5%

該報告深入探討了全球周邊動脈疾病治療市場的競爭格局。我們已經確定了在全球周邊動脈疾病治療市場中運作的關鍵參與者，並根據各種屬性對每個參與者進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告介紹的全球周邊動脈疾病治療市場參與者的屬性。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2035年全球周邊動脈疾病治療市場分析與預測

第5章：關鍵見解

  • 主要地區/國家的監管格局
  • 市場趨勢
  • 波特五力分析
  • PESTEL分析
  • 最終用戶的關鍵購買指標
  • 品牌和定價分析
  • 治療演算法
  • 重要產業活動

第6章：全球市場分析與預測：依藥物類型

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年藥品市場價值預測
    • 抗血小板藥物
    • 降膽固醇藥物（他汀類藥物）
    • 抗高血壓藥物
    • 降血壓藥
    • 血管擴張劑
    • 其他
  • 不同藥物類型的市場吸引力

第7章：全球市場分析與預測：依管理途徑

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年按給藥途徑分類的市場價值預測
    • 口服
    • 腸外
  • 按給藥途徑分類的市場吸引力

第8章：全球市場分析與預測：按配銷通路

  • 介紹和定義
  • 主要發現/進展
  • 2020-2035年配銷通路市場價值預測
    • 醫院藥房
    • 零售藥局
    • 網路藥局
  • 配銷通路的市場吸引力

第9章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第10章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第12章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 亞太其他地區

第13章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 各公司市佔率分析（2024 年）
  • 公司簡介
    • Bayer AG
    • Pfizer Inc.
    • Eli Lilly and Company
    • Cipla
    • Lupin
    • Viatris Inc
    • Johnson & Johnson Services, Inc.
    • Sanofi
    • Novartis AG
    • Amgen Inc.
    • Aurobindo Pharma Limited
    • Other Prominent Players
Product Code: TMRGL86559

Peripheral Arterial Disease Treatment Market - Scope of Report

TMR's report on the global peripheral arterial disease treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global peripheral arterial disease treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peripheral arterial disease treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the peripheral arterial disease treatment market.

Market Snapshot
Market Value in 2024US$ 2.9 Bn
Market Value in 2035US$ 6.4 Bn
CAGR7.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peripheral arterial disease treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peripheral arterial disease treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peripheral arterial disease treatment market.

The report delves into the competitive landscape of the global peripheral arterial disease treatment market. Key players operating in the global peripheral arterial disease treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peripheral arterial disease treatment market profiled in this report.

Key Questions Answered in Global peripheral arterial disease treatment market Report:

  • What is the sales/revenue generated by peripheral arterial disease treatment across all regions during the forecast period?
  • What are the opportunities in the global peripheral arterial disease treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Peripheral Arterial Disease Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global peripheral arterial disease treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peripheral arterial disease treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peripheral arterial disease treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Peripheral Arterial Disease Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Landscape across Key Regions / Countries
  • 5.2. Market Trends
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTEL Analysis
  • 5.5. Key Purchase Metrics for End-users
  • 5.6. Brand and Pricing Analysis
  • 5.7. Treatment Algorithm
  • 5.8. Key Industry Events

6. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Drug Type, 2020-2035
    • 6.3.1. Antiplatelet Drugs
    • 6.3.2. Cholesterol-Lowering Drugs (Statins)
    • 6.3.3. Anti-hypertensive Drugs
    • 6.3.4. Blood Pressure Medications
    • 6.3.5. Vasodilators
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Drug Type

7. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2035
    • 7.3.1. Oral
    • 7.3.2. Parenteral
  • 7.4. Market Attractiveness By Route of Administration

8. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Drug Type, 2020-2035
    • 10.2.1. Antiplatelet Drugs
    • 10.2.2. Cholesterol-Lowering Drugs (Statins)
    • 10.2.3. Anti-hypertensive Drugs
    • 10.2.4. Blood Pressure Medications
    • 10.2.5. Vasodilators
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Route of Administration, 2020-2035
    • 10.3.1. Oral
    • 10.3.2. Parenteral
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Drug Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Drug Type, 2020-2035
    • 11.2.1. Antiplatelet Drugs
    • 11.2.2. Cholesterol-Lowering Drugs (Statins)
    • 11.2.3. Anti-hypertensive Drugs
    • 11.2.4. Blood Pressure Medications
    • 11.2.5. Vasodilators
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Route of Administration, 2020-2035
    • 11.3.1. Oral
    • 11.3.2. Parenteral
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Drug Type
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Drug Type, 2020-2035
    • 12.2.1. Antiplatelet Drugs
    • 12.2.2. Cholesterol-Lowering Drugs (Statins)
    • 12.2.3. Anti-hypertensive Drugs
    • 12.2.4. Blood Pressure Medications
    • 12.2.5. Vasodilators
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020-2035
    • 12.3.1. Oral
    • 12.3.2. Parenteral
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Drug Type
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Drug Type, 2020-2035
    • 13.2.1. Antiplatelet Drugs
    • 13.2.2. Cholesterol-Lowering Drugs (Statins)
    • 13.2.3. Anti-hypertensive Drugs
    • 13.2.4. Blood Pressure Medications
    • 13.2.5. Vasodilators
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020-2035
    • 13.3.1. Oral
    • 13.3.2. Parenteral
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Drug Type
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Peripheral Arterial Disease Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Drug Type, 2020-2035
    • 14.2.1. Antiplatelet Drugs
    • 14.2.2. Cholesterol-Lowering Drugs (Statins)
    • 14.2.3. Anti-hypertensive Drugs
    • 14.2.4. Blood Pressure Medications
    • 14.2.5. Vasodilators
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020-2035
    • 14.3.1. Oral
    • 14.3.2. Parenteral
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Drug Type
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Pfizer Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Eli Lilly and Company
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Cipla
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Lupin
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Viatris Inc
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Johnson & Johnson Services, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Sanofi
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Novartis AG
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Amgen Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Aurobindo Pharma Limited
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Other Prominent Players
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments

List of Tables

  • Table 01: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 02: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 03: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 05: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 06: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 07: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 08: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country/ Sub-region, 2020-2035
  • Table 10: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 11: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 12: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 14: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 15: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 16: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 18: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 19: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 20: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 22: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
  • Table 23: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 24: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 02: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 03: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Antiplatelet Drugs, 2020-2035
  • Figure 04: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Cholesterol-Lowering Drugs (Statins), 2020-2035
  • Figure 05: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Anti-hypertensive Drugs, 2020-2035
  • Figure 06: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Blood Pressure Medications, 2020-2035
  • Figure 07: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Vasodilators, 2020-2035
  • Figure 08: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 09: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 10: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 11: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 12: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035
  • Figure 13: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 14: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 15: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
  • Figure 16: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 17: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 18: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 19: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 20: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 21: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 22: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 23: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 24: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 25: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 26: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 27: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 28: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 29: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 30: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 31: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 32: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 33: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 34: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 35: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 36: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 37: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 38: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 39: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 40: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 41: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 42: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 43: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 44: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 45: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 46: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 47: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 49: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 50: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 51: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 52: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 53: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 54: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 55: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 56: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 57: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 58: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 59: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
  • Figure 60: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
  • Figure 61: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 62: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 63: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 64: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035